DJO Global has reported third quarter sales of $274 million, up 4.1 percent compared to the same period last year.
Net sales for DJO's bracing and vascular segment increased 9.6 percent in the third quarter, while net sales for the recovery sciences segment fell by 1.3 percent. The company's surgical implant segment saw a 12.9 percent increase to $17.2 million.
More Articles on Orthopedic Devices:
Smith & Nephew Launches Endobutton
DSM, AxioMed Partner for Freedom Spine Device
MiMedx 3Q Revenue Grows 270% to $8M